[{"address1": "2500 Westchester Ave.", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 63, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 854148, "exercisedValue": 0, "unexercisedValue": 559838}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 414884, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 616275, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven A. Weissman Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bobby  Horn", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.5847, "open": 0.5976, "dayLow": 0.542, "dayHigh": 0.6008, "regularMarketPreviousClose": 0.5847, "regularMarketOpen": 0.5976, "regularMarketDayLow": 0.542, "regularMarketDayHigh": 0.6008, "beta": 1.447, "forwardPE": -0.5701042, "volume": 727548, "regularMarketVolume": 727548, "averageVolume": 911072, "averageVolume10days": 4182060, "averageDailyVolume10Day": 4182060, "bid": 0.5181, "ask": 0.5792, "bidSize": 200, "askSize": 200, "marketCap": 21924016, "fiftyTwoWeekLow": 0.542, "fiftyTwoWeekHigh": 2.95, "fiftyDayAverage": 1.71008, "twoHundredDayAverage": 1.794945, "currency": "USD", "enterpriseValue": -10214796, "floatShares": 33863451, "sharesOutstanding": 40058500, "sharesShort": 214807, "sharesShortPriorMonth": 180713, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.00557, "heldPercentInstitutions": 0.28732002, "shortRatio": 1.48, "shortPercentOfFloat": 0.0078, "impliedSharesOutstanding": 40058500, "bookValue": 0.761, "priceToBook": 0.7191853, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -28767000, "trailingEps": -0.93, "forwardEps": -0.96, "enterpriseToEbitda": 0.183, "52WeekChange": -0.64248365, "SandP52WeekChange": 0.19031036, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CGTX", "underlyingSymbol": "CGTX", "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "firstTradeDateEpochUtc": 1633699800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a940fdf5-8e87-319f-94b8-efcb91259f97", "messageBoardId": "finmb_39366358", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.5473, "targetHighPrice": 11.0, "targetLowPrice": 1.0, "targetMeanPrice": 6.6, "targetMedianPrice": 7.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 34671000, "totalCashPerShare": 0.866, "ebitda": -55751000, "totalDebt": 1034000, "quickRatio": 3.739, "currentRatio": 3.995, "debtToEquity": 3.583, "returnOnAssets": -0.82609004, "returnOnEquity": -0.89002997, "freeCashflow": -27673000, "operatingCashflow": -20557000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-11"}]